Developer docs
API playgroundTry for free, no card

Search company profiles

Biovex

Full company profile

uuid024zqsk

Namestring
Biovex
Legal namestring
Biovex International Trading FZ LLC
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRas Al Khaimah, United Arab Emirates
HQ citystring
Ras Al Khaimah
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vaccine distribution, human vaccines, veterinary vaccines, blood derivatives, biological products trading
Industry1 code
1Veterinary Vaccine & Biologics Distributors
CodeHLAMAIACPrimaryYes
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Pharmaceutical Distribution
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Vaccine Distribution
TypeOne Time License
Description

Sourcing and exporting human vaccines (bacterial and viral) and veterinary vaccines to international markets, primarily through government and institutional tender channels.

biovexhealthcare.com
2Blood Derivatives
TypeOne Time License
Description

Distribution of blood derivative products including human albumin, immunoglobulins, and factor VIII for medical treatments.

biovexhealthcare.com
3Specialty Products
TypeOne Time License
Description

Supply of antivenoms (snake and scorpion), botulinum toxin, rabies antiserum, and recombinant growth factors.

biovexhealthcare.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Biovex International Trading FZ LLC is an international trading company that sources and distributes human vaccines (bacterial and viral), veterinary vaccines, blood derivatives, and specialty biological products. The company procures WHO pre-qualified products from international manufacturers and exports them primarily through government and institutional tenders, with specialized cold chain logistics for temperature-sensitive biologics.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biovex International Trading FZ LLC is a pharmaceutical trading company offering a comprehensive portfolio of human and veterinary vaccines, blood derivatives, and specialty biological products. The core offerings include Bacterial Human Vaccines (BCG, Oral Cholera, Meningococcal, Typhoid), Viral Human Vaccines (Oral Polio, Rabies, Yellow Fever, Hepatitis B, Rotavirus, H1N1), and Veterinary Vaccines categorized by animal type (Poultry, Cattle, Sheep & Goat, Dog). Supporting products include Blood Derivatives (Human Normal Albumin, Human Normal Immunoglobulin, Dried Factor VIII) and Specialty Products (Snake Venom Antiserum, Botulinum Toxin, Rabies Antiserum, Recombinant Human EGF Gel, Anti-Scorpion Venom, Saccharomyces Boulardii). The company operates as a trading/distribution entity sourcing products from international manufacturers and exporting to 13+ African countries and 5+ Asian countries.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major global vaccine manufacturer and Sanofi's vaccines division. Competes with Biovex in emerging markets through direct distribution and supply to government immunization programs across Africa and Asia.

TypeRegional player
Description

Indonesian state-owned vaccine manufacturer, primarily serves domestic and ASEAN markets. Comparable in product portfolio (human and veterinary vaccines) and government procurement focus, though primarily focused on Indonesia.

TypeBroad incumbent
Description

Major global vaccine manufacturer with broad portfolio across pediatric, travel, and adult vaccines. Biovex competes indirectly by offering WHO pre-qualified alternatives in emerging markets where GSK also distributes directly to governments.

TypeDirect peer
Description

Indian vaccine manufacturer with portfolio including DPT, measles, hepatitis, and other vaccines for emerging markets. Comparable in scale, target geographies, and government tender focus.

TypeDirect peer
Description

Indian vaccine manufacturer with focus on emerging markets, including polio, rabies, rotavirus, and typhoid vaccines. Comparable in product categories, WHO pre-qualified product mix, and export-focused B2B model serving government immunization programs.

TypeEmerging player
Description

Indian state-owned vaccine and pharmaceutical manufacturer. Comparable in product portfolio including bacterial and viral vaccines and emerging market focus, though primarily serves domestic Indian markets.

TypeDirect peer
Description

Indian vaccine manufacturer with portfolio including polio, DPT, and other vaccines. Comparable in emerging market focus and B2B distribution model through government and institutional channels.

TypeDirect peer
Description

Chinese vaccine manufacturer with focus on emerging markets, including hepatitis, flu, and COVID vaccines. Comparable in export focus and B2B model serving government immunization programs in developing countries.

TypeDirect peer
Description

Largest vaccine manufacturer globally, exporting to 170+ countries including African and Asian government markets. Directly comparable in product portfolio (human vaccines such as polio, measles, BCG) and B2B export focus through institutional channels.

TypeDirect peer
Description

Indian vaccine manufacturer for both human and veterinary use, with strong emerging market presence. Comparable in product mix including veterinary vaccines and footprint in African and Asian government markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biovex

Pharmaceutical Distributionbiovexhealthcare.com

Biovex firmographics

Firmographics
Name
Biovex
Legal name
Biovex International Trading FZ LLC
Website
https://biovexhealthcare.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Biovex industry classification

Industry
Product category
Pharmaceutical Distribution
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Veterinary Vaccine & Biologics Distributors (HLAMAIAC)

Keywords

  • Vaccine distribution
  • Human vaccines
  • Veterinary vaccines
  • Blood derivatives
  • Biological products trading

Where Biovex is headquartered

Location

Headquarters

HQ city
Ras Al Khaimah
HQ country
United Arab Emirates
HQ region
Middle East

Offices1 record

Markets served

Biovex business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Vaccine Distribution: Sourcing and exporting human vaccines (bacterial and viral) and veterinary vaccines to international markets, primarily through government and institutional tender channels.
  2. Blood Derivatives: Distribution of blood derivative products including human albumin, immunoglobulins, and factor VIII for medical treatments.
  3. Specialty Products: Supply of antivenoms (snake and scorpion), botulinum toxin, rabies antiserum, and recombinant growth factors.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Biovex product offering

Product offering

Core offering

Biovex International Trading FZ LLC is an international trading company that sources and distributes human vaccines (bacterial and viral), veterinary vaccines, blood derivatives, and specialty biological products. The company procures WHO pre-qualified products from international manufacturers and exports them primarily through government and institutional tenders, with specialized cold chain logistics for temperature-sensitive biologics.

Product overview

Biovex International Trading FZ LLC is a pharmaceutical trading company offering a comprehensive portfolio of human and veterinary vaccines, blood derivatives, and specialty biological products. The core offerings include Bacterial Human Vaccines (BCG, Oral Cholera, Meningococcal, Typhoid), Viral Human Vaccines (Oral Polio, Rabies, Yellow Fever, Hepatitis B, Rotavirus, H1N1), and Veterinary Vaccines categorized by animal type (Poultry, Cattle, Sheep & Goat, Dog). Supporting products include Blood Derivatives (Human Normal Albumin, Human Normal Immunoglobulin, Dried Factor VIII) and Specialty Products (Snake Venom Antiserum, Botulinum Toxin, Rabies Antiserum, Recombinant Human EGF Gel, Anti-Scorpion Venom, Saccharomyces Boulardii). The company operates as a trading/distribution entity sourcing products from international manufacturers and exporting to 13+ African countries and 5+ Asian countries.

Differentiator

Problem solved

Functional benefit

Companies that use Biovex

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Biovex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Biovex partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Biovex competitors and assessment

Company assessment

Broad incumbents

  • Sanofi Pasteur: Major global vaccine manufacturer and Sanofi's vaccines division. Competes with Biovex in emerging markets through direct distribution and supply to government immunization programs across Africa and Asia.
  • GSK: Major global vaccine manufacturer with broad portfolio across pediatric, travel, and adult vaccines. Biovex competes indirectly by offering WHO pre-qualified alternatives in emerging markets where GSK also distributes directly to governments.

Regional players

  • PT Bio Farma: Indonesian state-owned vaccine manufacturer, primarily serves domestic and ASEAN markets. Comparable in product portfolio (human and veterinary vaccines) and government procurement focus, though primarily focused on Indonesia.

Direct peers

  • Biological E. Limited: Indian vaccine manufacturer with portfolio including DPT, measles, hepatitis, and other vaccines for emerging markets. Comparable in scale, target geographies, and government tender focus.
  • Bharat Biotech: Indian vaccine manufacturer with focus on emerging markets, including polio, rabies, rotavirus, and typhoid vaccines. Comparable in product categories, WHO pre-qualified product mix, and export-focused B2B model serving government immunization programs.
  • Panacea Biotec: Indian vaccine manufacturer with portfolio including polio, DPT, and other vaccines. Comparable in emerging market focus and B2B distribution model through government and institutional channels.
  • Sinovac Biotech: Chinese vaccine manufacturer with focus on emerging markets, including hepatitis, flu, and COVID vaccines. Comparable in export focus and B2B model serving government immunization programs in developing countries.
  • Serum Institute of India: Largest vaccine manufacturer globally, exporting to 170+ countries including African and Asian government markets. Directly comparable in product portfolio (human vaccines such as polio, measles, BCG) and B2B export focus through institutional channels.
  • Indian Immunologicals Limited: Indian vaccine manufacturer for both human and veterinary use, with strong emerging market presence. Comparable in product mix including veterinary vaccines and footprint in African and Asian government markets.

Emerging players

  • Haffkine Bio-Pharmaceutical Corporation: Indian state-owned vaccine and pharmaceutical manufacturer. Comparable in product portfolio including bacterial and viral vaccines and emerging market focus, though primarily serves domestic Indian markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Biovex compliance and trust

Trust signal

Compliance3 records

Biovex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biovex leadership team

Management profile

Number of profiles

Biovex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biovex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biovex

What does Biovex do?

Biovex International Trading FZ LLC is an international trading company that sources and distributes human vaccines (bacterial and viral), veterinary vaccines, blood derivatives, and specialty biological products. The company procures WHO pre-qualified products from international manufacturers and exports them primarily through government and institutional tenders, with specialized cold chain logistics for temperature-sensitive biologics.

Is Biovex a public or private company?

Biovex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biovex founded?

Biovex was founded in -1. It employs 11 to 50 people.

Where is Biovex based?

Biovex is headquartered in Ras Al Khaimah, United Arab Emirates, in the Middle East region.

How does Biovex make money?

Three revenue lines are on record. Vaccine Distribution is the primary driver. The others are blood Derivatives and specialty Products.

Who are Biovex's main competitors?

Broad incumbents on record are Sanofi Pasteur and GSK. PT Bio Farma is listed as a regional player. Direct peers are Biological E. Limited, Bharat Biotech, Panacea Biotec, Sinovac Biotech, Serum Institute of India and Indian Immunologicals Limited. Haffkine Bio-Pharmaceutical Corporation is listed as an emerging player.

Does Biovex have an API?

No public API is recorded for Biovex.

What industry is Biovex in?

Biovex's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAMAIAC, Veterinary Vaccine & Biologics Distributors. Its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales